Sandbox/AIRSG: Difference between revisions
Line 24: | Line 24: | ||
===Acute aortic insufficiency=== | ===Acute aortic insufficiency=== | ||
Shown below is an algorithm summarizing the approach to '''acute [[aortic insufficiency]] (AI)''' <ref name="2014 AHA">{{Cite web | last = | first = | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.full.pdf+html | publisher = | date = | accessdate = 4 March 2014 }}</ref><ref name="BonowCarabello2008">{{cite journal|last1=Bonow|first1=R. O.|last2=Carabello|first2=B. A.|last3=Chatterjee|first3=K.|last4=de Leon|first4=A. C.|last5=Faxon|first5=D. P.|last6=Freed|first6=M. D.|last7=Gaasch|first7=W. H.|last8=Lytle|first8=B. W.|last9=Nishimura|first9=R. A.|last10=O'Gara|first10=P. T.|last11=O'Rourke|first11=R. A.|last12=Otto|first12=C. M.|last13=Shah|first13=P. M.|last14=Shanewise|first14=J. S.|title=2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons|journal=Circulation|volume=118|issue=15|year=2008|pages=e523–e661|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.108.190748}}</ref> | Shown below is an algorithm summarizing the approach to '''acute [[aortic insufficiency]] (AI)''' <ref name="2014 AHA">{{Cite web | last = | first = | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.full.pdf+html | publisher = | date = | accessdate = 4 March 2014 }}</ref><ref name="BonowCarabello2008">{{cite journal|last1=Bonow|first1=R. O.|last2=Carabello|first2=B. A.|last3=Chatterjee|first3=K.|last4=de Leon|first4=A. C.|last5=Faxon|first5=D. P.|last6=Freed|first6=M. D.|last7=Gaasch|first7=W. H.|last8=Lytle|first8=B. W.|last9=Nishimura|first9=R. A.|last10=O'Gara|first10=P. T.|last11=O'Rourke|first11=R. A.|last12=Otto|first12=C. M.|last13=Shah|first13=P. M.|last14=Shanewise|first14=J. S.|title=2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons|journal=Circulation|volume=118|issue=15|year=2008|pages=e523–e661|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.108.190748}}</ref> | ||
'''Abbreviations:''' '''BP:''' [[blood pressure]]; '''CXR:''' [[chest X-ray]]; '''ECG:''' [[electrocardiogram]]; '''LV:''' [[left ventricle]] | |||
{{Family tree/start}} | {{Family tree/start}} | ||
Line 75: | Line 77: | ||
{{family tree | | | | | | | | |!| | | | | | | | | | | | | | | | }} | {{family tree | | | | | | | | |!| | | | | | | | | | | | | | | | }} | ||
{{Family tree | | | | | | | | Z01 | | | | | | | | | | | | | | Z01=<div style="float: left; text-align: left; width:30em; line-height: 150%; width:30em ">'''Treatment'''<br> | {{Family tree | | | | | | | | Z01 | | | | | | | | | | | | | | Z01=<div style="float: left; text-align: left; width:30em; line-height: 150%; width:30em ">'''Treatment'''<br> | ||
❑ The use of [[nitroprusside]] and [[Inotrope|inotropic agents]] (such as: [[dopamine]] and [[dobutamine]]) help reduce the LV end-diastolic pressure before surgery<br> | |||
❑ <span style="font-size:100%;color:red">Avoid the use of beta blockers because may block compensating tachycardia</span><br> | ❑ <span style="font-size:100%;color:red">Avoid the use of beta blockers because may block compensating tachycardia</span><br> | ||
</div>}} | </div>}} | ||
{{Family tree | | | | |,|-|-|-|^|-|-|-|-|-|-|.| | | | | | | |}} | {{Family tree | | | | |,|-|-|-|^|-|-|-|-|-|-|.| | | | | | | |}} | ||
{{Family tree | | | | C01 | | | | | | | | | C03 | | | | | | |C01=<div style="float: left; text-align: left; width: 24em line-height: 150% "> ''' | {{Family tree | | | | C01 | | | | | | | | | C03 | | | | | | |C01=<div style="float: left; text-align: left; width: 24em line-height: 150% "> '''[[Infective endocarditis]]''' </div> | C03=<div style="float: left; text-align: left; width: 24em line-height: 150% "> '''[[Aortic dissection]]''' </div>}} | ||
{{Family tree | |,|-|-|^|-|-|.| | | | | | | |!| | | | | |}} | {{Family tree | |,|-|-|^|-|-|.| | | | | | | |!| | | | | |}} | ||
{{Family tree | Y01 | | | | Y02 |-|-|-|-|-| Y03 | | | | |Y01=<div style="float: left; text-align: left; width: 18em line-height: 150% "> '''Mild or moderate''' </div> | Y02=<div style="float: left; text-align: left; width: 18em line-height: 150% "> '''Severe''' </div> | Y03=<div style="float: left; text-align: left; width: 24em line-height: 150% "> '''Urgent surgical intervention'''<br> | {{Family tree | Y01 | | | | Y02 |-|-|-|-|-| Y03 | | | | |Y01=<div style="float: left; text-align: left; width: 18em line-height: 150% "> '''Mild or moderate''' </div> | Y02=<div style="float: left; text-align: left; width: 18em line-height: 150% "> '''Severe''' </div> | Y03=❑<div style="float: left; text-align: left; width: 24em line-height: 150% "> '''Urgent surgical intervention'''<br> | ||
❑ Aortic valve replacement<br> | ❑ Aortic valve replacement<br> | ||
❑ <span style="font-size:100%;color:red">Intra-aortic balloon counterpulsation is contraindicated</span><br></div>}} | ❑ <span style="font-size:100%;color:red">Intra-aortic balloon counterpulsation is contraindicated</span><br></div>}} | ||
{{Family tree | |! | {{Family tree | |!| | | | | | | | | | | | | | | | | |}} | ||
{{Family tree | O01 | {{Family tree | O01 | | | | | | | | | | | | | | | | |O01=<div style="float: left; text-align: left; width: 12em line-height: 150% "> '''Antibiotic treatment''' <br> | ||
A complete list of pathogen specific antibiotics regimens with appropriate dosages and duration of treatment is available '''[[Endocarditis antimicrobial treatment|here]]'''</div>}} | A complete list of pathogen specific antibiotics regimens with appropriate dosages and duration of treatment is available '''[[Endocarditis antimicrobial treatment|here]]'''</div>}} | ||
{{Family tree/end}} | {{Family tree/end}} |
Revision as of 15:10, 1 April 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]
Overview
Aortic insufficiency refers to the retrograde or backward flow of blood from the aorta into the left ventricle during diastole.[1][2][3][4]
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
- Bicuspid aortic valve
- Senile or degenerative calcific aortic valve disease[5]
- Hypertension
- Idiopthic dialation of the aorta
- Myxomatous degeneration
- Rheumatic fever
Management
Acute aortic insufficiency
Shown below is an algorithm summarizing the approach to acute aortic insufficiency (AI) [6][7]
Abbreviations: BP: blood pressure; CXR: chest X-ray; ECG: electrocardiogram; LV: left ventricle
Inquire about past medical history: ❑ Previously healthy ❑ Cardiac disease: ❑ Rheumatic fever ❑ Pulmonary disease | |||||||||||||||||||||||||||||||||||||||||||||||||
Examine the patient: Vitals Cardiovascular
❑ Cardiac auscultation
❑ Search for other signs suggestive of aortic insufficiency
Respiratory | |||||||||||||||||||||||||||||||||||||||||||||||||
Order imaging studies: ❑ Order an echocardiography, assess:
❑ Order a CXR
![]()
❑ Order a ECG
| |||||||||||||||||||||||||||||||||||||||||||||||||
Treatment ❑ The use of nitroprusside and inotropic agents (such as: dopamine and dobutamine) help reduce the LV end-diastolic pressure before surgery | |||||||||||||||||||||||||||||||||||||||||||||||||
Mild or moderate | Severe | ❑ Urgent surgical intervention ❑ Aortic valve replacement | |||||||||||||||||||||||||||||||||||||||||||||||
Antibiotic treatment A complete list of pathogen specific antibiotics regimens with appropriate dosages and duration of treatment is available here | |||||||||||||||||||||||||||||||||||||||||||||||||
Chronic aortic insufficiency
Shown below is an algorithm summarizing the approach to chronic aortic insufficiency [6][7]
1111 | |||||||||||||||||||||||||||||||||||||||||||
Do's
❑
Don'ts
❑ Do not use beta blockers in AI of causes other than AD as it will block the compensation tachycardia. ❑ Do not use intra-aortic baloon counterpulsation in severe acute AI as it will increase the aortic diastolic pressure and the regurgitant volume.
References
- ↑ Connolly HM, Crary JL, McGoon MD; et al. (1997). "Valvular heart disease associated with fenfluramine-phentermine". N. Engl. J. Med. 337 (9): 581–8. doi:10.1056/NEJM199708283370901. PMID 9271479.
- ↑ Weissman NJ (2001). "Appetite suppressants and valvular heart disease". Am. J. Med. Sci. 321 (4): 285–91. doi:10.1097/00000441-200104000-00008. PMID 11307869.
- ↑ Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E (2007). "Dopamine agonists and the risk of cardiac-valve regurgitation". N. Engl. J. Med. 356 (1): 29–38. doi:10.1056/NEJMoa062222. PMID 17202453.
- ↑ Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G (2007). "Valvular heart disease and the use of dopamine agonists for Parkinson's disease". N. Engl. J. Med. 356 (1): 39–46. doi:10.1056/NEJMoa054830. PMID 17202454.
- ↑ Nishimura, RA. (2002). "Cardiology patient pages. Aortic valve disease". Circulation. 106 (7): 770–2. PMID 12176943. Unknown parameter
|month=
ignored (help) - ↑ 6.0 6.1 "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary". Retrieved 4 March 2014.
- ↑ 7.0 7.1 Bonow, R. O.; Carabello, B. A.; Chatterjee, K.; de Leon, A. C.; Faxon, D. P.; Freed, M. D.; Gaasch, W. H.; Lytle, B. W.; Nishimura, R. A.; O'Gara, P. T.; O'Rourke, R. A.; Otto, C. M.; Shah, P. M.; Shanewise, J. S. (2008). "2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 118 (15): e523–e661. doi:10.1161/CIRCULATIONAHA.108.190748. ISSN 0009-7322.
- ↑ Williams BR, Steinberg JP (2006). "Images in clinical medicine. Müller's sign". The New England Journal of Medicine. 355 (3): e3. doi:10.1056/NEJMicm050642. PMID 16855259. Retrieved 2012-04-15. Unknown parameter
|month=
ignored (help)